{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:12:31Z","timestamp":1794651151677,"version":"4.9.1"},"reference-count":232,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.autrev.2024.103541","type":"journal-article","created":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T22:31:54Z","timestamp":1712529114000},"page":"103541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Fecal microbiota transplantation in autoimmune diseases \u2013 An extensive paper on a pathogenetic therapy"],"prefix":"10.1016","volume":"23","author":[{"given":"Isa","family":"Seida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maisam","family":"Al Shawaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naim","family":"Mahroum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.autrev.2024.103541_bb0005","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nrgastro.2016.98","article-title":"Understanding the mechanisms of faecal microbiota transplantation","volume":"13","author":"Khoruts","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2024.103541_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mehy.2018.10.017","article-title":"Reverse phenotype transfer via fecal microbial transplantation in inflammatory bowel disease","volume":"122","author":"Liptak","year":"2019","journal-title":"Med Hypotheses"},{"issue":"3","key":"10.1016\/j.autrev.2024.103541_bb0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/19490976.2017.1293224","article-title":"Fecal microbiota transplantation in metabolic syndrome: history, present and future","volume":"8","author":"de Groot","year":"2017","journal-title":"Gut Microbes"},{"issue":"11","key":"10.1016\/j.autrev.2024.103541_bb0020","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/ajg.2012.251","article-title":"Should we standardize the 1,700-year-old fecal microbiota transplantation?","volume":"107","author":"Zhang","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.autrev.2024.103541_bb0025","first-page":"854","article-title":"Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis","volume":"44","author":"Eiseman","year":"1958","journal-title":"Surgery"},{"issue":"7164","key":"10.1016\/j.autrev.2024.103541_bb0030","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nature06244","article-title":"The human microbiome project","volume":"449","author":"Turnbaugh","year":"2007","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.autrev.2024.103541_bb0035","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/ni.2611","article-title":"The role of the immune system in governing host-microbe interactions in the intestine","volume":"14","author":"Brown","year":"2013","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2024.103541_bb0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nri3430","article-title":"Role of the gut microbiota in immunity and inflammatory disease","volume":"13","author":"Kamada","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2024.103541_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114620","article-title":"Role of microbiota short-chain fatty acids in the pathogenesis of autoimmune diseases","volume":"162","author":"Rasouli-Saravani","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"10.1016\/j.autrev.2024.103541_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103166","article-title":"The mosaic of autoimmunity - finally discussing in person. The 13(th) international congress on autoimmunity 2022 (AUTO13) Athens","volume":"21","author":"Mahroum","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"34","key":"10.1016\/j.autrev.2024.103541_bb0055","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7374","key":"10.1016\/j.autrev.2024.103541_bb0060","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature10554","article-title":"Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination","volume":"479","author":"Berer","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-065X.2011.01084.x","article-title":"The influence of the microbiota on type-1 diabetes: on the threshold of a leap forward in our understanding","volume":"245","author":"Mathis","year":"2012","journal-title":"Immunol Rev"},{"issue":"8","key":"10.1016\/j.autrev.2024.103541_bb0070","first-page":"1500","article-title":"Fecal microbiota in early rheumatoid arthritis","volume":"35","author":"Vaahtovuo","year":"2008","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2024.103541_bb0075","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1080\/1744666X.2023.2260103","article-title":"Triggers and regulation: the gut microbiome in rheumatoid arthritis","volume":"19","author":"Mahroum","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2024.103541_bb0080","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.autrev.2016.07.012","article-title":"Microbiota at the crossroads of autoimmunity","volume":"15","author":"Shamriz","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2024.103541_bb0085","doi-asserted-by":"crossref","first-page":"G568","DOI":"10.1152\/ajpgi.00201.2007","article-title":"Polyamines are required for expression of toll-like receptor 2 modulating intestinal epithelial barrier integrity","volume":"293","author":"Chen","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"22","key":"10.1016\/j.autrev.2024.103541_bb0090","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1016\/j.febslet.2014.04.007","article-title":"Microbial view of central nervous system autoimmunity","volume":"588","author":"Berer","year":"2014","journal-title":"FEBS Lett"},{"issue":"8","key":"10.1016\/j.autrev.2024.103541_bb0095","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ni.3780","article-title":"Regulation of inflammation by microbiota interactions with the host","volume":"18","author":"Blander","year":"2017","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2024.103541_bb0100","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cell.2016.12.021","article-title":"Discovery of reactive microbiota-derived metabolites that inhibit host proteases","volume":"168","author":"Guo","year":"2017","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.autrev.2024.103541_bb0105","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/apt.13144","article-title":"Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent clostridium difficile infection","volume":"41","author":"Cammarota","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"20","key":"10.1016\/j.autrev.2024.103541_bb0110","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.2017.17077","article-title":"Effect of oral capsule- vs colonoscopy-delivered fecal microbiota transplantation on recurrent clostridium difficile infection: a randomized clinical trial","volume":"318","author":"Kao","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.autrev.2024.103541_bb0115","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/cid\/civ938","article-title":"Safety and durability of RBX2660 (microbiota suspension) for recurrent clostridium difficile infection: results of the PUNCH CD study","volume":"62","author":"Orenstein","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.autrev.2024.103541_bb0120","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"van Nood","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2024.103541_bb0125","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-med-111717-122956","article-title":"Clinical application and potential of fecal microbiota transplantation","volume":"70","author":"Ooijevaar","year":"2019","journal-title":"Annu Rev Med"},{"issue":"3","key":"10.1016\/j.autrev.2024.103541_bb0130","article-title":"Regulation, risk and safety of faecal microbiota transplant","volume":"2","author":"Merrick","year":"2020","journal-title":"Infect Prev Pract"},{"issue":"10","key":"10.1016\/j.autrev.2024.103541_bb0135","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/ajg.2013.257","article-title":"Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation","volume":"108","author":"Angelberger","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.autrev.2024.103541_bb0140","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.crohns.2013.10.002","article-title":"Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn\u2019s disease and recurrent Clostridium difficile infection","volume":"8","author":"Quera","year":"2014","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.autrev.2024.103541_bb0145","series-title":"Ulcerative colitis","author":"Lynch","year":"2023"},{"issue":"10080","key":"10.1016\/j.autrev.2024.103541_bb0150","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2024.103541_bb0155","series-title":"Inflammatory bowel disease","author":"McDowell","year":"2023"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0160","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2019.11.003","article-title":"The microbiome and inflammatory bowel disease","volume":"145","author":"Glassner","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103541_bb0165","article-title":"Rules of engagement: epithelial-microbe interactions and inflammatory bowel disease","volume":"8","author":"Jergens","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.autrev.2024.103541_bb0170","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/ecco-jcc\/jjv223","article-title":"Mucosal barrier depletion and loss of bacterial diversity are primary abnormalities in Paediatric ulcerative colitis","volume":"10","author":"Alipour","year":"2016","journal-title":"J Crohns Colitis"},{"issue":"3","key":"10.1016\/j.autrev.2024.103541_bb0175","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","article-title":"The treatment-naive microbiome in new-onset Crohn\u2019s disease","volume":"15","author":"Gevers","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00535-017-1384-4","article-title":"Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease","volume":"53","author":"Nishino","year":"2018","journal-title":"J Gastroenterol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103541_bb0185","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1053\/j.gastro.2020.09.056","article-title":"Inflammatory bowel diseases (IBD) and the microbiome-searching the crime scene for clues","volume":"160","author":"Lee","year":"2021","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.autrev.2024.103541_bb0190","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1097\/CM9.0000000000002704","article-title":"What is the \u201coptimal formula\u201d for donor selection and feces processing for fecal microbiota transplantation in ulcerative colitis?","volume":"136","author":"Li","year":"2023","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0195","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial","volume":"149","author":"Moayyedi","year":"2015","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.autrev.2024.103541_bb0200","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/1751-2980.12933","article-title":"Efficacy and safety of fecal microbiota transplantation for treating patients with ulcerative colitis: a systematic review and meta-analysis","volume":"21","author":"Zhao","year":"2020","journal-title":"J Dig Dis"},{"issue":"4","key":"10.1016\/j.autrev.2024.103541_bb0205","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s13238-019-00684-8","article-title":"Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening","volume":"11","author":"Zhang","year":"2020","journal-title":"Protein Cell"},{"issue":"11","key":"10.1016\/j.autrev.2024.103541_bb0210","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/1751-2980.12938","article-title":"Efficacy and safety of fecal microbiota transplantation by washed preparation in patients with moderate to severely active ulcerative colitis","volume":"21","author":"Chen","year":"2020","journal-title":"J Dig Dis"},{"issue":"10","key":"10.1016\/j.autrev.2024.103541_bb0215","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/ecco-jcc\/jjx063","article-title":"Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis","volume":"11","author":"Paramsothy","year":"2017","journal-title":"J Crohns Colitis"},{"issue":"5","key":"10.1016\/j.autrev.2024.103541_bb0220","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1053\/j.gastro.2018.12.001","article-title":"Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis","volume":"156","author":"Paramsothy","year":"2019","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.autrev.2024.103541_bb0225","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1136\/gutjnl-2022-327811","article-title":"Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial","volume":"71","author":"Kedia","year":"2022","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.autrev.2024.103541_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238910","article-title":"Fecal microbiota transplantation in inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"15","author":"Caldeira","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2024.103541_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.944387","article-title":"Safety and efficacy of fecal microbiota transplantation for autoimmune diseases and autoinflammatory diseases: a systematic review and meta-analysis","volume":"13","author":"Zeng","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103541_bb0240","doi-asserted-by":"crossref","first-page":"1124256","DOI":"10.3389\/fcimb.2023.1124256","article-title":"Shifts and importance of viable bacteria in treatment of DSS-induced ulcerative colitis mice with FMT","volume":"13","author":"Liu","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0245","doi-asserted-by":"crossref","first-page":"1788898","DOI":"10.1080\/19490976.2020.1788898","article-title":"TH1 cell-inducing Escherichia coli strain identified from the small intestinal mucosa of patients with Crohn\u2019s disease","volume":"12","author":"Nagayama","year":"2020","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0250","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1038\/s41467-018-07359-8","article-title":"Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells","volume":"9","author":"Burrello","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0255","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/cei.13397","article-title":"Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease","volume":"199","author":"Quraishi","year":"2020","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2024.103541_bb0260","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/MIB.0000000000001132","article-title":"Single delivery of high-diversity fecal microbiota preparation by colonoscopy is safe and effective in increasing microbial diversity in active ulcerative colitis","volume":"23","author":"Jacob","year":"2017","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.autrev.2024.103541_bb0265","article-title":"Hashimoto thyroiditis: an evidence-based guide to etiology, diagnosis and treatment","volume":"132","author":"Klubo-Gwiezdzinska","year":"2022","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.autrev.2024.103541_bb0270","series-title":"Hashimoto thyroiditis","author":"Mincer","year":"2023"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0275","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","article-title":"Graves\u2019 disease","volume":"6","author":"Davies","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.autrev.2024.103541_bb0280","series-title":"Graves disease","author":"Pokhrel","year":"2023"},{"issue":"11","key":"10.1016\/j.autrev.2024.103541_bb0285","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1038\/s41396-021-01016-7","article-title":"Compositional and genetic alterations in Graves\u2019 disease gut microbiome reveal specific diagnostic biomarkers","volume":"15","author":"Zhu","year":"2021","journal-title":"ISME J"},{"key":"10.1016\/j.autrev.2024.103541_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.663131","article-title":"Alterations of gut microbiota in patients with Graves\u2019 disease","volume":"11","author":"Chang","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.autrev.2024.103541_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.774362","article-title":"Association between gut microbiota and autoimmune thyroid disease: a systematic review and meta-analysis","volume":"12","author":"Gong","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"10.1016\/j.autrev.2024.103541_bb0300","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1042\/CS20200475","article-title":"Gut dysbiosis is associated with primary hypothyroidism with interaction on gut-thyroid axis","volume":"134","author":"Su","year":"2020","journal-title":"Clin Sci (Lond)"},{"issue":"18","key":"10.1016\/j.autrev.2024.103541_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810729","article-title":"Gut Dysbiosis and fecal microbiota transplantation in autoimmune diseases","volume":"23","author":"Belvoncikova","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.autrev.2024.103541_bb0310","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11154-018-9467-y","article-title":"Gut microbiota and Hashimoto\u2019s thyroiditis","volume":"19","author":"Virili","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"10.1016\/j.autrev.2024.103541_bb0315","doi-asserted-by":"crossref","first-page":"173","DOI":"10.33073\/pjm-2022-016","article-title":"Alterations and mechanism of gut microbiota in Graves\u2019 disease and Hashimoto\u2019s thyroiditis","volume":"71","author":"Zhao","year":"2022","journal-title":"Pol J Microbiol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103541_bb0320","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/thy.2017.0395","article-title":"Alterations of the gut microbiota in Hashimoto\u2019s thyroiditis patients","volume":"28","author":"Zhao","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2024.103541_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.739707","article-title":"The role of the microbiota in Graves\u2019 disease and Graves\u2019 orbitopathy","volume":"11","author":"Hou","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"10.1016\/j.autrev.2024.103541_bb0330","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1089\/thy.2020.0193","article-title":"Gut microbiota may play a significant role in the pathogenesis of Graves\u2019 disease","volume":"31","author":"Jiang","year":"2021","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.autrev.2024.103541_bb0335","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/1751-7915.13793","article-title":"Cecal microbial transplantation attenuates hyperthyroid-induced thermogenesis in Mongolian gerbils","volume":"15","author":"Khakisahneh","year":"2022","journal-title":"J Microbial Biotechnol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0340","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40168-020-00952-4","article-title":"Modulating gut microbiota in a mouse model of Graves\u2019 orbitopathy and its impact on induced disease","volume":"9","author":"Moshkelgosha","year":"2021","journal-title":"Microbiome"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2024.103541_bb0345","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000452541","article-title":"Imbalance of Th17\/Treg in different subtypes of autoimmune thyroid diseases","volume":"40","author":"Li","year":"2016","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"10.1016\/j.autrev.2024.103541_bb0350","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000444471","article-title":"The pathogenesis of autoimmune liver disease","volume":"34","author":"Arndtz","year":"2016","journal-title":"Dig Dis"},{"issue":"5","key":"10.1016\/j.autrev.2024.103541_bb0355","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00292-020-00807-7","article-title":"Autoimmune liver diseases","volume":"41","author":"Fischer","year":"2020","journal-title":"Pathologe"},{"issue":"9","key":"10.1016\/j.autrev.2024.103541_bb0360","article-title":"Recent advances in the diagnosis and management of autoimmune hepatitis","volume":"132","author":"Dalekos","year":"2022","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.autrev.2024.103541_bb0365","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"380","author":"Muratori","year":"2023","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.autrev.2024.103541_bb0370","doi-asserted-by":"crossref","first-page":"430","DOI":"10.5009\/gnl19261","article-title":"Autoimmune hepatitis: 2019 update","volume":"14","author":"Tanaka","year":"2020","journal-title":"Gut Liver"},{"issue":"10266","key":"10.1016\/j.autrev.2024.103541_bb0375","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(20)31607-X","article-title":"Primary biliary cholangitis","volume":"396","author":"Lleo","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/cmh.2020.0028","article-title":"Current understanding of primary biliary cholangitis","volume":"27","author":"Tanaka","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.autrev.2024.103541_bb0385","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cca.2022.01.022","article-title":"Pathophysiology and immunogenetics of celiac disease","volume":"528","author":"Aboulaghras","year":"2022","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.autrev.2024.103541_bb0390","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s10620-019-05484-y","article-title":"Primary sclerosing cholangitis: a concise review of diagnosis and management","volume":"64","author":"Fricker","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.autrev.2024.103541_bb0395","doi-asserted-by":"crossref","first-page":"29","DOI":"10.21037\/tgh-20-266","article-title":"Primary sclerosing cholangitis","volume":"6","author":"Rabiee","year":"2021","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0400","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/cld.798","article-title":"Genetic and environmental risk factors for autoimmune hepatitis","volume":"14","author":"Lammert","year":"2019","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"4","key":"10.1016\/j.autrev.2024.103541_bb0405","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00281-022-00936-6","article-title":"The intestinal and biliary microbiome in autoimmune liver disease-current evidence and concepts","volume":"44","author":"Liwinski","year":"2022","journal-title":"Semin Immunopathol"},{"issue":"5","key":"10.1016\/j.autrev.2024.103541_bb0410","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jhep.2015.12.002","article-title":"Gut-liver immunity","volume":"64","author":"Trivedi","year":"2016","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103541_bb0415","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3934\/microbiol.2018.2.334","article-title":"Autoimmune liver disease and the enteric microbiome","volume":"4","author":"Glassner","year":"2018","journal-title":"AIMS Microbiol"},{"issue":"25","key":"10.1016\/j.autrev.2024.103541_bb0420","first-page":"2501","article-title":"Primary sclerosing cholangitis","volume":"375","author":"Lazaridis","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2024.103541_bb0425","doi-asserted-by":"crossref","first-page":"1126117","DOI":"10.3389\/fimmu.2023.1126117","article-title":"Gut microbial profile of treatment-naive patients with primary biliary cholangitis","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2024.103541_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20591","article-title":"Fecal microbiota transplantation regulates TFH\/TFR cell imbalance via TLR\/MyD88 pathway in experimental autoimmune hepatitis","volume":"9","author":"Ma","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.autrev.2024.103541_bb0435","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.728723","article-title":"Fecal microbiota transplantation controls progression of experimental autoimmune hepatitis in mice by modulating the TFR\/TFH immune imbalance and intestinal microbiota composition","volume":"12","author":"Liang","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0440","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1186\/s40064-016-2512-y","article-title":"Interleukin-21 plays a critical role in the pathogenesis and severity of type I autoimmune hepatitis","volume":"5","author":"Abe","year":"2016","journal-title":"Springerplus"},{"issue":"4","key":"10.1016\/j.autrev.2024.103541_bb0445","first-page":"958","article-title":"Targeting gut microbiota for the treatment of primary biliary cholangitis: from bench to bedside","volume":"11","author":"Zhang","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.autrev.2024.103541_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.947382","article-title":"The gut microbiota: a novel player in autoimmune hepatitis","volume":"12","author":"Cheng","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"44","key":"10.1016\/j.autrev.2024.103541_bb0455","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.3748\/wjg.v28.i44.6213","article-title":"Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value","volume":"28","author":"Li","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.autrev.2024.103541_bb0460","first-page":"438","article-title":"Healthy donor fecal microbiota transplantation for recurrent bacterial cholangitis in primary sclerosing cholangitis - a single case report","volume":"6","author":"Philips","year":"2018","journal-title":"J Clin Transl Hepatol"},{"issue":"4","key":"10.1016\/j.autrev.2024.103541_bb0465","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1474-4422(14)70305-9","article-title":"Role of the innate and adaptive immune responses in the course of multiple sclerosis","volume":"14","author":"Hemmer","year":"2015","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103541_bb0470","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","article-title":"Pathological mechanisms in progressive multiple sclerosis","volume":"14","author":"Mahad","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2024.103541_bb0475","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.3389\/fimmu.2018.03116","article-title":"Pathogenic mechanisms associated with different clinical courses of multiple sclerosis","volume":"9","author":"Lassmann","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103541_bb0480","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The immunopathology of multiple sclerosis: an overview","volume":"17","author":"Lassmann","year":"2007","journal-title":"Brain Pathol"},{"key":"10.1016\/j.autrev.2024.103541_bb0485","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-immunol-032713-120227","article-title":"Immunology of relapse and remission in multiple sclerosis","volume":"32","author":"Steinman","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2024.103541_bb0490","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3389\/fimmu.2020.01390","article-title":"Alterations in circulating fatty acid are associated with gut microbiota dysbiosis and inflammation in multiple sclerosis","volume":"11","author":"Saresella","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103541_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2019.104468","article-title":"Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis","volume":"129","author":"Zeng","year":"2019","journal-title":"Neurochem Int"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2024.103541_bb0500","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1073\/pnas.1000082107","article-title":"Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis","volume":"108","author":"Lee","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.autrev.2024.103541_bb0505","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41582-022-00697-8","article-title":"The role of the gut microbiota in multiple sclerosis","volume":"18","author":"Correale","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2024.103541_bb0510","series-title":"Bacteroides Fragilis","author":"Elsaghir","year":"2023"},{"issue":"5","key":"10.1016\/j.autrev.2024.103541_bb0515","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/mi.2010.29","article-title":"A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease","volume":"3","author":"Ochoa-Reparaz","year":"2010","journal-title":"Mucosal Immunol"},{"issue":"6032","key":"10.1016\/j.autrev.2024.103541_bb0520","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.1206095","article-title":"The toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota","volume":"332","author":"Round","year":"2011","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.autrev.2024.103541_bb0525","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/19490976.2015.1056973","article-title":"A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function","volume":"6","author":"Telesford","year":"2015","journal-title":"Gut Microbes"},{"issue":"2","key":"10.1016\/j.autrev.2024.103541_bb0530","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/135245859900500206","article-title":"Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis","volume":"5","author":"Matusevicius","year":"1999","journal-title":"Mult Scler"},{"issue":"11","key":"10.1016\/j.autrev.2024.103541_bb0535","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/glia.24239","article-title":"The LncRNA AK018453 regulates TRAP1\/Smad signaling in IL-17-activated astrocytes: a potential role in EAE pathogenesis","volume":"70","author":"Zhang","year":"2022","journal-title":"Glia"},{"issue":"40","key":"10.1016\/j.autrev.2024.103541_bb0540","doi-asserted-by":"crossref","first-page":"10719","DOI":"10.1073\/pnas.1711233114","article-title":"Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice","volume":"114","author":"Berer","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"40","key":"10.1016\/j.autrev.2024.103541_bb0545","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1073\/pnas.1711235114","article-title":"Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models","volume":"114","author":"Cekanaviciute","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2024.103541_bb0550","doi-asserted-by":"crossref","first-page":"28484","DOI":"10.1038\/srep28484","article-title":"Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.autrev.2024.103541_bb0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137429","article-title":"Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters","volume":"10","author":"Miyake","year":"2015","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.autrev.2024.103541_bb0560","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.chom.2019.10.008","article-title":"Oral administration of miR-30d from feces of MS patients suppresses MS-like symptoms in mice by expanding Akkermansia muciniphila","volume":"26","author":"Liu","year":"2019","journal-title":"Cell Host Microbe"},{"issue":"7","key":"10.1016\/j.autrev.2024.103541_bb0565","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.4049\/jimmunol.1001443","article-title":"Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide a expression","volume":"185","author":"Ochoa-Reparaz","year":"2010","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2024.103541_bb0570","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/aps.2009.101","article-title":"Periplocoside a prevents experimental autoimmune encephalomyelitis by suppressing IL-17 production and inhibits differentiation of Th17 cells","volume":"30","author":"Zhang","year":"2009","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"10.1016\/j.autrev.2024.103541_bb0575","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000459","article-title":"Fecal microbiota transplantation associated with 10 years of stability in a patient with SPMS","volume":"5","author":"Makkawi","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"10.1016\/j.autrev.2024.103541_bb0580","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021001","article-title":"The role of fecal microbiota transplantation in the treatment of neurodegenerative diseases: a review","volume":"24","author":"Matheson","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2024.103541_bb0585","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3389\/fneur.2020.00978","article-title":"Single-arm, non-randomized, time series, single-subject study of fecal microbiota transplantation in multiple sclerosis","volume":"11","author":"Engen","year":"2020","journal-title":"Front Neurol"},{"issue":"12","key":"10.1016\/j.autrev.2024.103541_bb0590","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11122840","article-title":"The potential role of fecal microbiota transplant in the reversal or stabilization of multiple sclerosis symptoms: A literature review on efficacy and safety","volume":"11","author":"Laeeq","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.autrev.2024.103541_bb0595","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.autrev.2024.103541_bb0600","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","article-title":"Autoimmunity and organ damage in systemic lupus erythematosus","volume":"21","author":"Tsokos","year":"2020","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2024.103541_bb0605","first-page":"225","article-title":"Lupus nephritis: from diagnosis to treatment","volume":"64","author":"Weinmann-Menke","year":"2023","journal-title":"Inn Med (Heidelb)"},{"issue":"7","key":"10.1016\/j.autrev.2024.103541_bb0610","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/annrheumdis-2018-214856","article-title":"Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal","volume":"78","author":"Azzouz","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2024.103541_bb0615","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/art.41511","article-title":"An autoimmunogenic and proinflammatory profile defined by the gut microbiota of patients with untreated systemic lupus erythematosus","volume":"73","author":"Chen","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2024.103541_bb0620","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaut.2018.10.009","article-title":"Shared gut, but distinct oral microbiota composition in primary Sjogren\u2019s syndrome and systemic lupus erythematosus","volume":"97","author":"van der Meulen","year":"2019","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.autrev.2024.103541_bb0625","first-page":"255","article-title":"Monoclonal anti-tuberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with mycobacterium tuberculosis","volume":"66","author":"Shoenfeld","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2024.103541_bb0630","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/683489","article-title":"A possible link between infection with burkholderia bacteria and systemic lupus erythematosus based on epitope mimicry","volume":"2008","author":"Zhang","year":"2008","journal-title":"Clin Dev Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2024.103541_bb0635","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01548-14","article-title":"Intestinal dysbiosis associated with systemic lupus erythematosus","volume":"5","author":"Hevia","year":"2014","journal-title":"mBio"},{"issue":"2","key":"10.1016\/j.autrev.2024.103541_bb0640","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/cei.12609","article-title":"Impact of dietary deviation on disease progression and gut microbiome composition in lupus-prone SNF1 mice","volume":"181","author":"Johnson","year":"2015","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0645","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13075-021-02620-w","article-title":"Gut microbiota mediated the therapeutic efficacies and the side effects of prednisone in the treatment of MRL\/lpr mice","volume":"23","author":"Wang","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2024.103541_bb0650","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3389\/fmicb.2020.00628","article-title":"Early and short-term interventions in the gut microbiota affects lupus severity, progression, and treatment in MRL\/lpr mice","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.autrev.2024.103541_bb0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102844","article-title":"Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: an EXPLORER trial","volume":"130","author":"Huang","year":"2022","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0660","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40168-017-0300-8","article-title":"Control of lupus nephritis by changes of gut microbiota","volume":"5","author":"Mu","year":"2017","journal-title":"Microbiome"},{"key":"10.1016\/j.autrev.2024.103541_bb0665","article-title":"Fecal microbiota transplantation in the treatment of systemic lupus erythematosus: what we learnt from the explorative clinical trial","volume":"103058","author":"Xin","year":"2023","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2024.103541_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102989","article-title":"A single-cell map of peripheral alterations after FMT treatment in patients with systemic lupus erythematosus","volume":"135","author":"Zheng","year":"2023","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2024.103541_bb0675","article-title":"Gut microbiome and metabolites in systemic lupus erythematosus: link, mechanisms and intervention","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103541_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109096","article-title":"Will fecal microbiota transplantation eventually be an effective therapeutic strategy for systemic lupus erythematosus?","volume":"242","author":"Ciccia","year":"2022","journal-title":"Clin Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2024.103541_bb0685","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10157-012-0593-7","article-title":"Membranous nephropathy in Japan: analysis of the Japan renal biopsy registry (J-RBR)","volume":"16","author":"Yokoyama","year":"2012","journal-title":"Clin Exp Nephrol"},{"issue":"10032","key":"10.1016\/j.autrev.2024.103541_bb0690","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(16)00272-5","article-title":"Primary glomerulonephritides","volume":"387","author":"Floege","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.autrev.2024.103541_bb0695","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.kint.2019.07.014","article-title":"The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery","volume":"96","author":"van de Logt","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2024.103541_bb0700","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.557368","article-title":"A comparative study of the gut microbiota associated with immunoglobulin a nephropathy and membranous nephropathy","volume":"10","author":"Dong","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"10.1016\/j.autrev.2024.103541_bb0705","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1080\/10408398.2020.1761771","article-title":"Intestinal microbiota alterations in chronic kidney disease and the influence of dietary components","volume":"61","author":"Ondrussek-Sekac","year":"2021","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"28","key":"10.1016\/j.autrev.2024.103541_bb0710","article-title":"Gut microbiome analysis can be used as a noninvasive diagnostic tool and plays an essential role in the onset of membranous nephropathy","volume":"9","author":"Shang","year":"2022","journal-title":"Adv Sci (Weinh)"},{"issue":"11\u221212","key":"10.1016\/j.autrev.2024.103541_bb0715","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000533537","article-title":"Altered intestinal microbial flora and metabolism in patients with idiopathic membranous nephropathy","volume":"54","author":"Shi","year":"2023","journal-title":"Am J Nephrol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103541_bb0720","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13730-020-00560-z","article-title":"Fecal microbiota transplantation for membranous nephropathy","volume":"10","author":"Zhou","year":"2021","journal-title":"CEN Case Rep"},{"issue":"7480","key":"10.1016\/j.autrev.2024.103541_bb0725","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2024.103541_bb0730","series-title":"Rheumatoid arthritis","author":"Chauhan","year":"2023"},{"issue":"11","key":"10.1016\/j.autrev.2024.103541_bb0735","doi-asserted-by":"crossref","DOI":"10.3390\/cells10112857","article-title":"Management of rheumatoid arthritis: an overview","volume":"10","author":"Radu","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.autrev.2024.103541_bb0740","doi-asserted-by":"crossref","first-page":"1131933","DOI":"10.3389\/fimmu.2023.1131933","article-title":"Relationship between gut microbiota and rheumatoid arthritis: a bibliometric analysis","volume":"14","author":"Dong","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103541_bb0745","article-title":"Characteristics of the gut microbiome and its relationship with peripheral CD4(+) T cell subpopulations and cytokines in rheumatoid arthritis","volume":"13","author":"Wang","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.autrev.2024.103541_bb0750","doi-asserted-by":"crossref","first-page":"1007165","DOI":"10.3389\/fimmu.2022.1007165","article-title":"Gut microbiota and rheumatoid arthritis: from pathogenesis to novel therapeutic opportunities","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0755","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41398-022-01993-z","article-title":"Fecal microbiota transplantation from patients with rheumatoid arthritis causes depression-like behaviors in mice through abnormal T cells activation","volume":"12","author":"Pu","year":"2022","journal-title":"Transl Psychiatry"},{"issue":"2","key":"10.1016\/j.autrev.2024.103541_bb0760","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/ccr3.3677","article-title":"Fecal microbiota transplantation for rheumatoid arthritis: a case report","volume":"9","author":"Zeng","year":"2021","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.autrev.2024.103541_bb0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103001","article-title":"Gut microbiota in pre-clinical rheumatoid arthritis: from pathogenesis to preventing progression","volume":"141","author":"Lin","year":"2023","journal-title":"J Autoimmun"},{"issue":"10","key":"10.1016\/j.autrev.2024.103541_bb0770","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/art.42616","article-title":"Alteration of gut microbiota in individuals at high-risk for rheumatoid arthritis associated with disturbed metabolome and the initiation of arthritis through the triggering of mucosal immunity imbalance","volume":"75","author":"Luo","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2024.103541_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104603","article-title":"Magnesium increases numbers of Foxp3+ Treg cells and reduces arthritis severity and joint damage in an IL-10-dependent manner mediated by the intestinal microbiome","volume":"92","author":"Laragione","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.autrev.2024.103541_bb0780","doi-asserted-by":"crossref","first-page":"4","DOI":"10.12703\/r\/12-4","article-title":"Recent advances in graft-versus-host disease","volume":"12","author":"Flinn","year":"2023","journal-title":"Fac Rev"},{"issue":"5","key":"10.1016\/j.autrev.2024.103541_bb0785","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1128\/aem.62.5.1589-1592.1996","article-title":"Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora","volume":"62","author":"Miller","year":"1996","journal-title":"Appl Environ Microbiol"},{"issue":"6145","key":"10.1016\/j.autrev.2024.103541_bb0790","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0795","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1038\/s41467-018-05901-2","article-title":"Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis","volume":"9","author":"Sun","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0800","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1038\/s41467-020-18262-6","article-title":"Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity","volume":"11","author":"Yang","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.autrev.2024.103541_bb0805","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.6799","article-title":"Gut microbiota, microbiota-derived metabolites, and graft-versus-host disease","volume":"13","author":"Yue","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.autrev.2024.103541_bb0810","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.644982","article-title":"Interplay between the intestinal microbiota and acute graft-versus-host disease: experimental evidence and clinical significance","volume":"12","author":"Hong","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2024.103541_bb0815","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10040837","article-title":"The role of fecal microbiota transplantation in the treatment of acute graft-versus-host disease","volume":"10","author":"Bilinski","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0820","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2991\/chi.d.190316.002","article-title":"Fecal microbiota transplantation for treatment of acute graft-versus-host disease","volume":"1","author":"Shouval","year":"2019","journal-title":"Clin Hematol Int"},{"issue":"5","key":"10.1016\/j.autrev.2024.103541_bb0825","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2016.154351","article-title":"Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease","volume":"102","author":"Spindelboeck","year":"2017","journal-title":"Haematologica"},{"issue":"16","key":"10.1016\/j.autrev.2024.103541_bb0830","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1182\/blood-2016-05-717652","article-title":"Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut","volume":"128","author":"Kakihana","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0835","doi-asserted-by":"crossref","first-page":"2178805","DOI":"10.1080\/19490976.2023.2178805","article-title":"Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease","volume":"15","author":"van Lier","year":"2023","journal-title":"Gut Microbes"},{"issue":"23","key":"10.1016\/j.autrev.2024.103541_bb0840","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1158\/1078-0432.CCR-23-2369","article-title":"Potential of fecal microbiota transplantation to prevent acute GVHD: analysis from a phase II trial","volume":"29","author":"Rashidi","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0845","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s40164-022-00350-6","article-title":"Fecal microbiota transplantation combined with ruxolitinib as a salvage treatment for intestinal steroid-refractory acute GVHD","volume":"11","author":"Liu","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.autrev.2024.103541_bb0850","first-page":"5","article-title":"Recent advances in primary Sjogren\u2019s syndrome","author":"Holdgate","year":"2016","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0855","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2013-203845","article-title":"Comparison of the American-European consensus group Sjogren\u2019s syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort","volume":"73","author":"Rasmussen","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"22","key":"10.1016\/j.autrev.2024.103541_bb0860","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228733","article-title":"Connection between the gut microbiome, systemic inflammation, gut permeability and FOXP3 expression in patients with primary Sjogren\u2019s syndrome","volume":"21","author":"Cano-Ortiz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2024.103541_bb0865","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ajo.2021.06.022","article-title":"Fecal microbial transplant in individuals with immune-mediated dry eye","volume":"233","author":"Watane","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103541_bb0870","article-title":"Sjogren\u2019s syndrome treatments in the microbiome era","volume":"5","author":"Freguia","year":"2023","journal-title":"Adv Geriatr Med Res"},{"issue":"9","key":"10.1016\/j.autrev.2024.103541_bb0875","article-title":"Insights into microbiota in Sjogren\u2019s syndrome","volume":"vol. 59","author":"Mieliauskaite","year":"2023","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"10.1016\/j.autrev.2024.103541_bb0880","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020294","article-title":"Crosstalk between gut microbiota and host immunity: impact on inflammation and immunotherapy","volume":"11","author":"Campbell","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.autrev.2024.103541_bb0885","doi-asserted-by":"crossref","first-page":"1108738","DOI":"10.3389\/fneur.2023.1108738","article-title":"The role of the gut microbiota and fecal microbiota transplantation in neuroimmune diseases","volume":"14","author":"Wu","year":"2023","journal-title":"Front Neurol"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2024.103541_bb0890","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.2337\/dc22-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in Diabetes-2022","volume":"45","author":"American Diabetes Association Professional Practice C. 2","year":"2022","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb0895","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2017-000466","article-title":"Association of type 1 diabetes and concentrations of drinking water components in Newfoundland and Labrador, Canada","volume":"6","author":"Chafe","year":"2018","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"6","key":"10.1016\/j.autrev.2024.103541_bb0900","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2337\/dc18-2282","article-title":"Predicting islet cell autoimmunity and type 1 diabetes: an 8-year TEDDY study progress report","volume":"42","author":"Krischer","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autrev.2024.103541_bb0905","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.envres.2015.03.024","article-title":"Maternal exposure to air pollution and type 1 diabetes\u2013Accounting for genetic factors","volume":"140","author":"Malmqvist","year":"2015","journal-title":"Environ Res"},{"issue":"6","key":"10.1016\/j.autrev.2024.103541_bb0910","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1542\/peds.2013-1652","article-title":"Genetic and epigenetic factors in etiology of diabetes mellitus type 1","volume":"132","author":"Stankov","year":"2013","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.autrev.2024.103541_bb0915","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.immuni.2010.03.018","article-title":"Prediction and pathogenesis in type 1 diabetes","volume":"32","author":"Ziegler","year":"2010","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.autrev.2024.103541_bb0920","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1007\/s00125-015-3614-8","article-title":"A model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes","volume":"58","author":"Davis-Richardson","year":"2015","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.autrev.2024.103541_bb0925","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00125-014-3274-0","article-title":"Aberrant gut microbiota composition at the onset of type 1 diabetes in young children","volume":"57","author":"de Goffau","year":"2014","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.autrev.2024.103541_bb0930","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188475","article-title":"Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study","volume":"12","author":"de Groot","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2024.103541_bb0935","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.722206","article-title":"Gut bacterial characteristics of patients with type 2 diabetes mellitus and the application potential","volume":"12","author":"Que","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2024.103541_bb0940","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cmet.2021.05.005","article-title":"Fecal microbiota transplantation in human metabolic diseases: from a murky past to a bright future?","volume":"33","author":"Hanssen","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.autrev.2024.103541_bb0945","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101076","article-title":"Infusion of donor feces affects the gut-brain axis in humans with metabolic syndrome","volume":"42","author":"Hartstra","year":"2020","journal-title":"Mol Metab"},{"issue":"50","key":"10.1016\/j.autrev.2024.103541_bb0950","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013543","article-title":"Fecal microbiota transplantation relieve painful diabetic neuropathy: a case report","volume":"97","author":"Cai","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2024.103541_bb0955","doi-asserted-by":"crossref","DOI":"10.1177\/20406223221117449","article-title":"Fecal microbiota transplantation treatment for type 1 diabetes mellitus with malnutrition: a case report","volume":"13","author":"Xie","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"issue":"3","key":"10.1016\/j.autrev.2024.103541_bb0960","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2022-003282","article-title":"Fecal microbiota transplantation ameliorates type 2 diabetes via metabolic remodeling of the gut microbiota in db\/db mice","volume":"11","author":"Chen","year":"2023","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.autrev.2024.103541_bb0965","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.3389\/fmicb.2017.02430","article-title":"Fecal microbiota transplantation, commensal Escherichia coli and Lactobacillus johnsonii strains differentially restore intestinal and systemic adaptive immune cell populations following broad-spectrum antibiotic treatment","volume":"8","author":"Ekmekciu","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.autrev.2024.103541_bb0970","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3389\/fphys.2019.01607","article-title":"Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes","volume":"10","author":"Zatterale","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.autrev.2024.103541_bb0975","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fcimb.2019.00455","article-title":"Promising treatment for type 2 diabetes: fecal microbiota transplantation reverses insulin resistance and impaired islets","volume":"9","author":"Wang","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.autrev.2024.103541_bb0980","doi-asserted-by":"crossref","first-page":"1114424","DOI":"10.3389\/fendo.2023.1114424","article-title":"Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus","volume":"14","author":"Wu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.autrev.2024.103541_bb0985","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103038","article-title":"Fecal microbiota transplantation: emerging applications in autoimmune diseases","volume":"141","author":"Yang","year":"2023","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.autrev.2024.103541_bb0990","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00261-016-1034-y","article-title":"Celiac disease: a clinical review","volume":"42","author":"Al-Bawardy","year":"2017","journal-title":"Abdom Radiol (NY)"},{"issue":"19","key":"10.1016\/j.autrev.2024.103541_bb0995","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911748","article-title":"Celiac disease and possible dietary interventions: from enzymes and probiotics to postbiotics and viruses","volume":"23","author":"Wagh","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.autrev.2024.103541_bb1000","doi-asserted-by":"crossref","DOI":"10.3390\/cells12060823","article-title":"Interaction between gut microbiota and celiac disease: from pathogenesis to treatment","volume":"12","author":"Rossi","year":"2023","journal-title":"Cells"},{"issue":"26","key":"10.1016\/j.autrev.2024.103541_bb1005","doi-asserted-by":"crossref","first-page":"11971","DOI":"10.1073\/pnas.1002601107","article-title":"Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns","volume":"107","author":"Dominguez-Bello","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb1010","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/aje\/kwu101","article-title":"Association of maternal education, early infections, and antibiotic use with celiac disease: a population-based birth cohort study in northeastern Italy","volume":"180","author":"Canova","year":"2014","journal-title":"Am J Epidemiol"},{"issue":"14","key":"10.1016\/j.autrev.2024.103541_bb1015","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.1021\/jf201212m","article-title":"Influence of Bifidobacterium longum CECT 7347 and gliadin peptides on intestinal epithelial cell proteome","volume":"59","author":"Olivares","year":"2011","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.autrev.2024.103541_bb1020","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3389\/fimmu.2020.00957","article-title":"Gut microbiota in celiac disease: is there any role for probiotics?","volume":"11","author":"Pecora","year":"2020","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2024.103541_bb1025","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/MIB.0b013e31828029a9","article-title":"The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease","volume":"19","author":"Wacklin","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"10.1016\/j.autrev.2024.103541_bb1030","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/ajg.2014.355","article-title":"Altered duodenal microbiota composition in celiac disease patients suffering from persistent symptoms on a long-term gluten-free diet","volume":"109","author":"Wacklin","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.autrev.2024.103541_bb1035","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bpg.2015.04.001","article-title":"T-cell and B-cell immunity in celiac disease","volume":"29","author":"du Pre","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.autrev.2024.103541_bb1040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bpg.2015.05.001","article-title":"Innate immunity: actuating the gears of celiac disease pathogenesis","volume":"29","author":"Kim","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"14","key":"10.1016\/j.autrev.2024.103541_bb1045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23147513","article-title":"Type 2 transglutaminase in coeliac disease: a key player in pathogenesis, diagnosis and therapy","volume":"23","author":"Paolella","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.autrev.2024.103541_bb1050","doi-asserted-by":"crossref","DOI":"10.3390\/nu10081123","article-title":"Autoantibodies in the extraintestinal manifestations of celiac disease","volume":"10","author":"Yu","year":"2018","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.autrev.2024.103541_bb1055","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1136\/gut.2007.129882","article-title":"Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease","volume":"57","author":"Fina","year":"2008","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.autrev.2024.103541_bb1060","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/mi.2013.19","article-title":"Increased production of interleukin-21, but not interleukin-17A, in the small intestine characterizes pediatric celiac disease","volume":"6","author":"van Leeuwen","year":"2013","journal-title":"Mucosal Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2024.103541_bb1065","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.immuni.2012.06.006","article-title":"Celiac disease: an immunological jigsaw","volume":"36","author":"Meresse","year":"2012","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.autrev.2024.103541_bb1070","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1007\/s00394-020-02324-y","article-title":"Role of the gut microbiota in the pathogenesis of coeliac disease and potential therapeutic implications","volume":"59","author":"Akobeng","year":"2020","journal-title":"Eur J Nutr"},{"issue":"3","key":"10.1016\/j.autrev.2024.103541_bb1075","doi-asserted-by":"crossref","first-page":"385","DOI":"10.15403\/jgld.2014.1121.253.cel","article-title":"Serendipity in refractory celiac disease: full recovery of duodenal villi and clinical symptoms after fecal microbiota transfer","volume":"25","author":"van Beurden","year":"2016","journal-title":"J Gastrointestin Liver Dis"},{"issue":"5","key":"10.1016\/j.autrev.2024.103541_bb1080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis - autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb1085","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12916-021-02034-0","article-title":"Metagenome-wide association study of gut microbiome revealed potential microbial marker set for diagnosis of pediatric myasthenia gravis","volume":"19","author":"Liu","year":"2021","journal-title":"BMC Med"},{"key":"10.1016\/j.autrev.2024.103541_bb1090","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.3389\/fmicb.2018.02627","article-title":"Altered gut microbiota in myasthenia gravis","volume":"9","author":"Qiu","year":"2018","journal-title":"Front Microbiol"},{"issue":"11","key":"10.1016\/j.autrev.2024.103541_bb1095","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8111715","article-title":"The influence of probiotics on the Firmicutes\/Bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease","volume":"8","author":"Stojanov","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.autrev.2024.103541_bb1100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clim.2019.05.006","article-title":"Inhibition of ROCK activity regulates the balance of Th1, Th17 and Treg cells in myasthenia gravis","volume":"203","author":"Song","year":"2019","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2024.103541_bb1105","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s10875-012-9685-0","article-title":"Changes of Treg-associated molecules on CD4+CD25 +Treg cells in myasthenia gravis and effects of immunosuppressants","volume":"32","author":"Xu","year":"2012","journal-title":"J Clin Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2024.103541_bb1110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-3083.2010.02432.x","article-title":"Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation","volume":"72","author":"Jager","year":"2010","journal-title":"Scand J Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb1115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12967-024-04965-7","article-title":"An angel or a devil? Current view on the role of CD8(+) T cells in the pathogenesis of myasthenia gravis","volume":"22","author":"Peng","year":"2024","journal-title":"J Transl Med"},{"issue":"18","key":"10.1016\/j.autrev.2024.103541_bb1120","doi-asserted-by":"crossref","first-page":"1901441","DOI":"10.1002\/advs.201901441","article-title":"Perturbed microbial ecology in myasthenia gravis: evidence from the gut microbiome and fecal metabolome","volume":"6","author":"Zheng","year":"2019","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb1125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13020-023-00798-6","article-title":"Astragaloside IV ameliorates experimental autoimmune myasthenia gravis by regulating CD4 + T cells and altering gut microbiota","volume":"18","author":"Weng","year":"2023","journal-title":"Chinas Med"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb1130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41572-021-00293-y","article-title":"Psoriatic arthritis","volume":"7","author":"FitzGerald","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.autrev.2024.103541_bb1135","series-title":"Psoriatic arthritis. StatPearls. Treasure Island (FL)","author":"Tiwari","year":"2023"},{"issue":"6","key":"10.1016\/j.autrev.2024.103541_bb1140","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2020.101494","article-title":"The gut microbiome in psoriasis and psoriatic arthritis","volume":"33","author":"Myers","year":"2019","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2024.103541_bb1145","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41584-022-00776-6","article-title":"Psoriatic arthritis from a mechanistic perspective","volume":"18","author":"Schett","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"10136","key":"10.1016\/j.autrev.2024.103541_bb1150","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0140-6736(18)30830-4","article-title":"The pathogenesis of psoriatic arthritis","volume":"391","author":"Veale","year":"2018","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.autrev.2024.103541_bb1155","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1136\/annrheumdis-2020-219511","article-title":"Safety and efficacy of faecal microbiota transplantation for active peripheral psoriatic arthritis: an exploratory randomised placebo-controlled trial","volume":"80","author":"Kragsnaes","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2024.103541_bb1160","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003750","article-title":"Dynamics of inflammation-associated plasma proteins following faecal microbiota transplantation in patients with psoriatic arthritis and healthy controls: exploratory findings from the FLORA trial","volume":"10","author":"Kragsnaes","year":"2024","journal-title":"RMD Open"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224000326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224000326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T16:52:31Z","timestamp":1725468751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997224000326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":232,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1568997224000326"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103541","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fecal microbiota transplantation in autoimmune diseases \u2013 An extensive paper on a pathogenetic therapy","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103541"}}